Location History:
- San Francisco, CA (US) (1991)
- Menlo Park, CA (US) (1994 - 2003)
Company Filing History:
Years Active: 1991-2003
Title: Inventor Spotlight: Susan L. Bernhard
Introduction
Susan L. Bernhard is an accomplished inventor based in Menlo Park, California, renowned for her significant contributions to the fields of biotechnology and pharmaceutical science. With four patents to her name, Bernhard's innovative work focuses on improving the efficiency and effectiveness of therapeutic agents.
Latest Patents
Bernhard's latest patents illustrate her dedication to advancing healthcare solutions. One of her notable inventions is titled "Methods of conditioning an affinity resin after storage." This invention relates to methods for conditioning affinity chromatography resins to decrease the leaching of the ligand during purification. By incubating the resin in a buffered solution of a hydroxyalkylamine compound (such as ethanolamine) before use, the treatment effectively removes unstably bound ligands, enhancing the purification process.
Another significant contribution is her patent concerning "Materials comprising and methods of preparation and use for." This invention provides purified and isolated polynucleotides encoding Type I ribosome-inactivating proteins (RIPs), such as gelonin and its analogs. The developed vectors and host cells transformed with these polynucleotides are intended as components for cytotoxic therapeutic agents. These agents aim to selectively eliminate specific cell types, making them particularly useful in treating diseases such as autoimmune disorders, cancer, and graft-versus-host disease.
Career Highlights
Throughout her career, Susan L. Bernhard has held pivotal roles in renowned organizations that contribute to her inventive prowess. She has been associated with Xoma Corporation and Baxter International Inc., where she has applied her expertise to develop groundbreaking therapies and technologies.
Collaborations
Working alongside notable individuals has enriched Bernhard’s journey in the realm of invention. Noteworthy colleagues include Marc D. Better and Steve F. Carroll, with whom she has likely collaborated on various innovative projects, further enhancing her contributions to biotechnology.
Conclusion
Susan L. Bernhard's dedication to advancements in biotechnology is evident through her patents and career achievements. Her inventive spirit continues to inspire progress in the medical field, ensuring that her work has a lasting impact on therapeutic solutions worldwide.